Menu
Sign In Search Podcasts Charts People & Topics Add Podcast API Pricing
Podcast Image

EndoDirect - Endocrinologia e Metabologia

FD 55 - Semaglutida oral reduz desfechos cardiovasculares?

01 Apr 2025

Description

Neste FD discutiremos o estudo recém-publicado no New England e apresentado no Congresso Americano de Cardiologia, estudo SOUL, que avaliou a eficácia da semaglutida oral na redução de desfechos cardiovasculares em pacientes diabéticos tipo 2.

Audio
Featured in this Episode

No persons identified in this episode.

Transcription

This episode hasn't been transcribed yet

Help us prioritize this episode for transcription by upvoting it.

0 upvotes
🗳️ Sign in to Upvote

Popular episodes get transcribed faster

Comments

There are no comments yet.

Please log in to write the first comment.